Keyphrases
Pulmonary Hypertension
100%
Pulmonary Edema
100%
Platelet-activating Factor
100%
Isolated Perfused Lung
100%
BN52021
100%
Lung
27%
Wetting-drying
27%
Lung Weight
27%
Dose Effect
18%
Weight Ratio
18%
Perfusion Pressure
18%
Intravenous Administration
9%
Receptor-mediated
9%
Pharmacologic
9%
Pathophysiologic
9%
Lung Edema
9%
Prostaglandin F2α
9%
Capillary Permeability
9%
Internal Control
9%
Left Pulmonary Artery
9%
Right Pulmonary Artery
9%
Platelet-activating Factor Receptor
9%
Pulmonary Pressure
9%
Lung Model
9%
Medicine and Dentistry
Lung
100%
Pulmonary Hypertension
100%
Pulmonary Edema
100%
Platelet-Activating Factor
100%
Ginkgolide B
100%
Thrombocyte Activating Factor Antagonist
33%
In Vitro
11%
Capillary Permeability
11%
Right Pulmonary Artery
11%
Left Pulmonary Artery
11%
Thrombocyte Activating Factor Receptor
11%
Prostaglandin F2
11%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Edema
100%
Thrombocyte Activating Factor
100%
Ginkgolide B
100%
Pulmonary Hypertension
100%
Thrombocyte Activating Factor Antagonist
37%
Prostaglandin F2
12%
Thrombocyte Activating Factor Receptor
12%